Certified Global Research Member

Key Questions Answered

Global Market Outlook
In-depth analysis of global and regional trends
Analyze and identify the major players in the market, their market share, key developments, etc.
To understand the capability of the major players based on products offered, financials, and strategies.
Identify disrupting products, companies, and trends.
To identify opportunities in the market.
Analyze the key challenges in the market.
Analyze the regional penetration of players, products, and services in the market.
Comparison of major playersâ€™ financial performance.
Evaluate strategies adopted by major players.
Recommendations

Why Choose Market Research Future?

Vigorous research methodologies for specific market.
Knowledge partners across the globe
Large network of partner consultants.
Ever-increasing/ Escalating data base with quarterly monitoring of various markets
Trusted by fortune 500 companies/startups/ universities/organizations
Large database of 5000+ markets reports.
Effective and prompt pre- and post-sales support.

Oral Thrush Companies

Oral thrush, also known as oropharyngeal candidiasis, is a fungal infection caused by Candida species, typically Candida albicans. While there may not be specific companies exclusively focused on oral thrush, various pharmaceutical companies and healthcare organizations provide antifungal medications and treatments that are used to manage fungal infections, including oral thrush.

Oral Thrush Key Companies

Latest Oral Thrush Companies Update

GlaxoSmithKline (GSK) acquires Paratek Pharmaceuticals: December 2023 deal bolsters GSK's antifungal portfolio, giving them access to Paratek's leading oral thrush medication, Noxafil (posaconazole).

Theravance Biopharma Collaborates with Almirall Laboratories: September 2023 partnership focuses on developing new antifungal therapies for oral thrush and other fungal infections, potentially leading to more effective and targeted treatment options.

Mylan Laboratories launches generic miconazole for oral thrush: October 2023 approval broadens access to a cost-effective treatment option for patients in the US.

Bayer receives EU approval for Canesten® (clotrimazole) 10mg lozenges: November 2023 approval offers a new formulation for treating oral thrush in adults, providing an alternative to traditional oral gels or suspensions.

List of Oral Thrush Key Companies in the Market

Bayer AG

Teva Pharmaceuticals

Stellar Pharma

Pfizer Inc.

Wockhardt Ltd.

Ranbaxy Laboratories Limited

Bristol Laboratories

Glenmark Pharmaceuticals

GlaxoSmithKline Plc

Oral Thrush Market Highlights:

Oral Thrush Market Size

Oral Thrush Market Trends

Oral Thrush Market Analysis

Oral Thrush Market Share

Oral Thrush Market Highlights:

Oral Thrush Market Trends

Oral Thrush Market Analysis

Oral Thrush Market Share

Oral Thrush Companies

Leading companies partner with us for data-driven Insights

Kindly complete the form below to receive a free sample of this Report

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
	Single User	$ 4,950
	Multiuser License	$ 5,950
	Enterprise User	$ 7,250
Compare Licenses

Tailored for You

Dedicated Research on any specifics segment or region.
Focused Research on specific players in the market.
Custom Report based only on your requirements.
Flexibility to add or subtract any chapter in the study.
Historic data from 2014 and forecasts outlook till 2040.
Flexibility of providing data/insights in formats (PDF, PPT, Excel).
Provide cross segmentation in applicable scenario/markets.